{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T02:00:11Z","timestamp":1787536811745,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ygyno.2011.10.014","type":"journal-article","created":{"date-parts":[[2011,10,19]],"date-time":"2011-10-19T23:34:55Z","timestamp":1319067295000},"page":"335-339","source":"Crossref","is-referenced-by-count":64,"title":["Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer"],"prefix":"10.1016","volume":"124","author":[{"given":"Keiichiro","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Imafuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ieyasu","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Joja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.10.014_bb0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","article-title":"Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0010","series-title":"Annual report of Oncology Committee of Japan Society of Obstetrics and Gynecology, Tokyo, Japan","year":"2011"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0090-8258(84)90063-5","article-title":"Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients","volume":"17","author":"Aalders","year":"1984","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0025","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0002-9378(80)91024-8","article-title":"Prognosis and treatment of endometrial cancer","volume":"136","author":"Berman","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0030","first-page":"825","article-title":"Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study","volume":"63","author":"Boronow","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0035","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0090-8258(91)90334-2","article-title":"Lymphvascular space involvement\u2014a prognostic indicator in endometrial adenocarcinoma","volume":"42","author":"Gal","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0045","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0029-7844(96)00161-5","article-title":"Prognostic significance of gross myometrial invasion with endometrial cancer","volume":"88","author":"Larson","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000131270","article-title":"Serum CA-125 level after 6cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer","volume":"31","author":"Kim","year":"2008","journal-title":"Onkologie"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0055","first-page":"12","article-title":"Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma","volume":"84","author":"Rose","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0060","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0002-9378(86)90358-3","article-title":"CA 125: a useful marker in endometrial carcinoma","volume":"155","author":"Duk","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0065","first-page":"661","article-title":"Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix","volume":"73","author":"Duk","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0070","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/jmri.21358","article-title":"Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas","volume":"27","author":"Dudeck","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1148\/radiol.2241010637","article-title":"Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics","volume":"224","author":"Guo","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1148\/radiol.2261011904","article-title":"Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients","volume":"226","author":"Taouli","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0085","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1148\/radiol.2472070823","article-title":"Renal masses: characterization with diffusion-weighted MR imaging\u2014a preliminary experience","volume":"247","author":"Zhang","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0090","first-page":"1419","article-title":"Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity","volume":"27","author":"Hayashida","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0095","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ejcts.2008.12.039","article-title":"Role of diffusion-weighted magnetic resonance imaging for predicting of tumor invasiveness for clinical stage IA non-small cell lung cancer","volume":"35","author":"Kanauchi","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0100","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1148\/radiol.2512080880","article-title":"Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging","volume":"251","author":"Taouli","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0105","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.2214\/AJR.06.1403","article-title":"Diffusion-weighted MRI in the body: applications and challenges in oncology","volume":"188","author":"Koh","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/nbm.1245","article-title":"Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy","volume":"22","author":"Sharma","year":"2009","journal-title":"NMR Biomed"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0115","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/jmri.20997","article-title":"Diffusion-weighted MR imaging of uterine endometrial cancer","volume":"26","author":"Tamai","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0120","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1148\/rg.293085130","article-title":"Diffusion-weighted MR imaging of female pelvic tumors: a pictorial review","volume":"29","author":"Whittaker","year":"2009","journal-title":"Radiographics"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0125","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1148\/radiol.2503080874","article-title":"Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging\u2014initial experience","volume":"250","author":"Lin","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0130","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1148\/radiol.2393042031","article-title":"Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response","volume":"239","author":"Provenzale","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neurad.2007.04.002","article-title":"Apparent diffusion coefficients of benign and malignant salivary gland tumors. Comparison to histopathological findings","volume":"34","author":"Matsushima","year":"2007","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0140","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s00330-005-0133-x","article-title":"Role of diffusion-weighted MR imaging in cervical lymphadenopathy","volume":"16","author":"Abdel Razek","year":"2006","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0145","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1148\/radiol.2452061535","article-title":"Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity","volume":"245","author":"Humphries","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0150","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/gyno.1994.1217","article-title":"Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma","volume":"54","author":"Takeshima","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0029-7844(97)00286-X","article-title":"Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome","volume":"90","author":"Sood","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.10.014_bb0160","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/0002-9378(90)90692-Z","article-title":"Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma","volume":"163","author":"Soper","year":"1990","journal-title":"Am J Obstet Gynecol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811008560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811008560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T04:25:26Z","timestamp":1543465526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811008560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0090825811008560"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.10.014","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}